De Vivo I - Search Results

1

Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States).

Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. Setiawan VW, et al. Among authors: de vivo i. Cancer Causes Control. 2004 Aug;15(6):627-33. doi: 10.1023/B:CACO.0000036170.28502.5f. Cancer Causes Control. 2004. PMID: 15280642

2

Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers.

De Vivo I, Gertig DM, Nagase S, Hankinson SE, O'Brien R, Speizer FE, Parsons R, Hunter DJ. De Vivo I, et al. J Med Genet. 2000 May;37(5):336-41. doi: 10.1136/jmg.37.5.336. J Med Genet. 2000. PMID: 10807691 Free PMC article.

3

A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.

Haiman CA, Hankinson SE, Spiegelman D, De Vivo I, Colditz GA, Willett WC, Speizer FE, Hunter DJ. Haiman CA, et al. Among authors: de vivo i. Int J Cancer. 2000 Jul 15;87(2):204-10. Int J Cancer. 2000. PMID: 10861475

4

A polymorphism in CYP17 and endometrial cancer risk.

Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. Haiman CA, et al. Among authors: de vivo i. Cancer Res. 2001 May 15;61(10):3955-60. Cancer Res. 2001. PMID: 11358812

5

Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.

Guillemette C, De Vivo I, Hankinson SE, Haiman CA, Spiegelman D, Housman DE, Hunter DJ. Guillemette C, et al. Among authors: de vivo i. Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):711-4. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11401924

6

Association of CYP1B1 polymorphisms and breast cancer risk.

De Vivo I, Hankinson SE, Li L, Colditz GA, Hunter DJ. De Vivo I, et al. Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):489-92. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12010864

7

MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD.

Hernán MA, Checkoway H, O'Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A. Hernán MA, et al. Among authors: de vivo i. Neurology. 2002 May 14;58(9):1381-7. doi: 10.1212/wnl.58.9.1381. Neurology. 2002. PMID: 12011284

8

Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.

Miller DP, Liu G, De Vivo I, Lynch TJ, Wain JC, Su L, Christiani DC. Miller DP, et al. Among authors: de vivo i. Cancer Res. 2002 May 15;62(10):2819-23. Cancer Res. 2002. PMID: 12019159

9

A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk.

De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ. De Vivo I, et al. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12263-8. doi: 10.1073/pnas.192172299. Epub 2002 Sep 6. Proc Natl Acad Sci U S A. 2002. PMID: 12218173 Free PMC article.

10

No association between a stop codon polymorphism in RAD52 and breast cancer risk.

Han J, Hankinson SE, De Vivo I, Colditz GA, Hunter DJ. Han J, et al. Among authors: de vivo i. Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1138-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12376524 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters